The value of progression-free survival at three years as a primary endpoint for studies on radiotherapy in patients with locally advanced cervical cancer: Individual patient data from Chinese National Cancer Center and validation from 27 global...
- Resource Type
- Article
- Source
- Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p5534-5534, 1p
- Subject
- Language
- ISSN
- 0732183X